Aquestive Therapeutics
AQST
AQST
65 hedge funds and large institutions have $102M invested in Aquestive Therapeutics in 2020 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 17 increasing their positions, 21 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
65
Holders Change
+5
Holders Change %
+8.33%
% of All Funds
1.15%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
15
Increased
17
Reduced
21
Closed
10
Calls
$295K
Puts
$898K
Net Calls
-$603K
Net Calls Change
+$443K
Top Buyers
| 1 |
Nuveen Asset Management
Chicago,
Illinois
|
+$2.18M |
| 2 |
Renaissance Technologies
New York
|
+$1.45M |
| 3 |
Nisa Investment Advisors
St. Louis,
Missouri
|
+$348K |
| 4 |
Squarepoint
New York
|
+$229K |
| 5 |
Bank of New York Mellon
New York
|
+$209K |
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$3.25M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$2.16M |
| 3 |
PA
Perceptive Advisors
New York
|
-$1.95M |
| 4 |
WS
Wedbush Securities
Los Angeles,
California
|
-$501K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$488K |
